Portage Biotech Hosting Key Opinion Leader Event on Targeting the Adenosine Pathway in Cancer

Targeting Adenosine for Cancer:Challenging Past Assumptions with Next-Generation Small Molecule Inhibitors Thursday, March 9th @ 10:30 am ET WESTPORT, Conn., Feb. 27, 2023 -- Portage Biotech Inc.... | February 27, 2023

Related Keywords

California ,United States ,Texas ,San Francisco ,Westport ,Lawrence Fong ,Gwendolyn Schanker ,Sumit Subudhi ,Chuck Padala ,University Of California ,Department Of Genitourinary Medical Oncology ,Linkedin ,University Of Texas Md Anderson Cancer Center ,Cancer Immunology Program ,Md Anderson Cancer Center ,Portage Biotech Inc ,Nasdaq ,Company Annual Report On Form ,Division Of Hematology Oncology ,Parker Institute For Cancer Immunotherapy ,Cancer Immunotherapy Program ,Department Of Medicine ,Helen Diller Family Comprehensive Cancer Center ,Globenewswire Inc ,Targeting Adenosine ,Past Assumptions ,Next Generation Small Molecule ,Cancer Center ,Efim Guzik Distinguished Professor ,Cancer Biology ,Diller Family Comprehensive Cancer ,Associate Professor ,Genitourinary Medical Oncology ,Portage Biotech ,Annual Report ,Portage Biotech Inc Stock Exchange ,News ,Information ,Press Release ,Targeting ,Adenosine ,Or ,Mast ,Assumptions ,Ith ,Mall ,Olecule ,Inhibitors ,Arch ,M ,023 ,Portage ,Iotech Prtg Vgg7185a1286 ,